Clinical Trials Directory

Trials / Completed

CompletedNCT00005586

Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed

A UKCCCR Study of Adjuvant Chemotherapy for Colorectal Cancer

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
2,500 (estimated)
Sponsor
Institute of Cancer Research, United Kingdom · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known whether chemotherapy is more effective than observation in patients who have had surgery to remove colorectal cancer. PURPOSE: This randomized phase III trial is studying leucovorin and fluorouracil to see how well they work compared to observation in treating patients with colorectal cancer that has been surgically removed.

Detailed description

OBJECTIVES: * Compare all-cause mortality in patients with resected colorectal cancer treated with adjuvant chemotherapy with L-leucovorin and fluorouracil vs observation. * Compare the recurrence rates in patients treated with this regimen vs observation. * Compare the effectiveness of a monthly 5-day schedule vs a once weekly schedule of L-leucovorin and fluorouracil in this patient population. OUTLINE: This is a randomized, open-label, multicenter study. Patients are randomized to receive adjuvant chemotherapy (arm I) or undergo observation only (arm II). * Arm I: Within 12 weeks of surgery, patients receive L-leucovorin IV followed by fluorouracil IV on days 1-5 every 4 weeks for 6 courses. Alternatively, patients may receive L-leucovorin IV followed by fluorouracil IV on day 1 weekly for 30 weeks. * Arm II: Patients undergo observation. Patients are followed annually. PROJECTED ACCRUAL: A total of 2,500 patients (1,250 per arm) will be accrued for this study.

Conditions

Interventions

TypeNameDescription
DRUGL-leucovorin
DRUGfluorouracil
PROCEDUREadjuvant therapy

Timeline

Start date
1997-10-01
First posted
2003-01-27
Last updated
2013-12-18

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00005586. Inclusion in this directory is not an endorsement.